Recent Security Class Actions

Rain Oncology Inc. (NASDAQ: RAIN)

Company Name:Rain Oncology Inc.
Stock Symbol:NASDAQ: RAIN
Class Period Start:04/23/2021
Class Period End (inclusive):05/19/2023
Filing Deadline:09/12/2023

The Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company concealed risks inherent in the design of its Phase 3 MANTRA study particularly with regard to proceeding directly to Phase 3 from Phase 1; and, (ii) as a result, the Company’s statements about the trial and the likelihood of FDA approval were materially misleading during the Class Period.